PULSE BIOSCIENCES, INC. current report, 23 May 2018

Pulse Biosciences, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. on May 23, 2018, regarding the results of its Annual Meeting of Stockholders held on the same date in Hayward, California. The Company is an emerging growth company incorporated in Nevada.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.

Material Changes and Voting Results

Stockholders voted on and approved four key proposals:

  • Election of Directors: Six nominees were elected to serve until the 2019 annual meeting. All nominees received significant "For" votes, ranging from approximately 8.8 million to 9.1 million, with "Against" votes ranging from approximately 50,000 to 305,000.
  • Reincorporation: Stockholders approved the reincorporation of the Company from the State of Nevada to the State of Delaware. The vote was 8,741,618 For, 377,913 Against, and 308,484 Abstained.
  • Indemnification Agreement: Stockholders approved the adoption of the Company's Form of Indemnification Agreement. The vote was 8,758,870 For, 355,041 Against, and 314,104 Abstained.
  • Appointment of Auditors: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2018. The vote was 14,727,142 For, 43,612 Against, and 347,615 Abstained.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote.

Key Facts for Investor Verification

  • Confirm the legal status of the Company's reincorporation from Nevada to Delaware.
  • Verify the terms of the newly adopted Form of Indemnification Agreement.
  • Review the full proxy statement for details on the director nominees and their qualifications.
  • Check subsequent filings for the official certificate of incorporation filed in Delaware.